Welcome To Biovotec.

Biovotec's products are positioned to rapidly become the preferred solution in the market for hard-to-heal and chronic wounds.

 

Biovotec has carried out clinical trials in the UK for our lead product, DermaRep™.

DermaRep™ has the potential to offer unrivalled cost-efficiency for both hospitals and society at large. 

Mission

Our mission is to make advanced wound care treatment affordable and available for everybody, from the moment they need it.

ISO_13485_2016.jpg

Biovotec certified ISO 13485:2016 & EN ISO 13485:2016